Craniosacral Therapy Clinical Trials

• Hormone Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
  adenocarcinoma of the prostate
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
  brain metastases
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
  Head and Neck Cancer
  
• Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
  Cancer
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
  Cancer
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Enzastaurin in Treating Patients With Recurrent Gliomas
  ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
  adult brain tumor
  
• Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
  Lung Cancer
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
  
• Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
  Head and Neck Cancer
  
• Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
  ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
  localized tumors of the Ewing's family
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
  adult glioblastoma
  
• Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Sorafenib in Treating Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
  Stage IV Melanoma
  
• GW786034 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
  ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
  Behavior Therapy
  
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
  adult soft tissue sarcoma
  
• Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
  Lymphoma
  
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
  renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
  ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
  Cancer
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer
  
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
  Cancer; oral complications of cancer and cancer therapy
  
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
  adult brain tumor
  
• ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
  Non-small cell lung cancer
  
• Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00049296 - Active, not recruiting
  Cancer
  
• SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
  ClinicalTrials.gov Identifier: NCT00006247 - Active, not recruiting
  Brain Cancer
  
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
  Central Nervous System Tumor; Brain Tumor
  
• Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
  stage II melanoma
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027729 - Active, not recruiting
  recurrent colon cancer; recurrent rectal cancer
  
• Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00104988 - Active, not recruiting
  Stage IV Melanoma
  
• SU011248 in Treating Women With Metastatic Breast Cancer That Did Not Respond to Anthracycline or Taxane Chemotherapy
  ClinicalTrials.gov Identifier: NCT00095615 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
  Burkitt's Lymphoma; Lymphocytic Lymphoma
  
• Thalidomide in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00015821 - Active, not recruiting
  Agnogenic Myeloid Metaplasia
  
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
  recurrent prostate cancer
  
• Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
  Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00025233 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00064168 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Lymphocyte Therapy in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002589 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
  
• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00053885 - Active, not recruiting
  advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
  
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00255762 - Active, not recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00031564 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
  recurrent prostate cancer
  
• Radiation Therapy With or Without Epoetin alfa in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017277 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Peripheral Stem Cell Transplantation, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00005941 - Active, not recruiting
  Cervical Cancer; Vaginal Cancer
  
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00052273 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
  ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00101309 - Active, not recruiting
  recurrent neuroblastoma; recurrent tumors of the Ewing's family
  
• Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003489 - Active, not recruiting
  Head and Neck Cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00112918 - Active, not recruiting
  stage II colon cancer; stage III colon cancer
  
• Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer